Skip to content

Clinical trials

Phase 3 Lung Neoplasms trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 3 Country / region: Mexico Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20071
20091
20101
20121
20131
20151
20181
20202
20211
20221
20232
20243
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting8
Active, not recruiting4
Terminated3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche3
Merck Sharp & Dohme LLC3
Amgen2
Bristol-Myers Squibb2
Eli Lilly and Company2
Genzyme, a Sanofi Company2
Novartis Pharmaceuticals2
Boehringer Ingelheim1
Genentech, Inc.1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms24
Carcinoma, Non-Small-Cell Lung20
Neoplasms4
Carcinoma3
Lung Diseases3
Carcinoma, Bronchogenic2
Neoplasms by Site2
Respiratory Tract Diseases2
Respiratory Tract Neoplasms2
Thoracic Neoplasms2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.